Conviction
$ Value
$535K
Shares
74,268
Price
$7
Filed
Apr 13
▶ Why this score? (6/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $250K (+1)
- ✓ 10%+ owner (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
RA CAPITAL MANAGEMENT, L.P.
Title
—
CIK
0001346824
Roles
Transaction Details
Transaction Date
2026-02-19
Code
P
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
1,107,873
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.89 to $7.20 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein. | Held directly by the Fund. | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.89 to $7.48 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.05 to $7.58 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Filing Info
RA CAPITAL MANAGEMENT, L.P.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-22 | ACRV | A | $7.0M |
| 2026-04-20 | VOR | ▼ | $2.7M |
| 2026-04-17 | VOR | ▼ | $7.5M |
| 2026-04-15 | VOR | ▼ | $859K |
| 2026-04-14 | VOR | ▼ | $2.5M |
| 2026-04-13 | VOR | ▼ | $8.6M |
| 2026-04-10 | VOR | ▼ | $13K |
| 2026-04-09 | VOR | ▼ | $2.2M |
| 2026-04-08 | VOR | ▼ | $5.8M |
| 2026-04-08 | VOR | ▼ | $2.2M |
Other Insiders at ACET (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $1.1M | — | 2026-02-20 |
| ORBIMED ADVISORS LLC | — | $675K | 2026-04-08 |
|
Schor Chen
President & CEO
|
— | — | 2026-03-25 |
|
Harvey Brian Nicholas
Chief Financial Officer
|
— | — | 2026-03-25 |
|
Healey Don
Chief Technology Officer
|
— | — | 2026-03-25 |
|
Aftab Blake
Chief Scientific Officer
|
— | — | 2026-03-25 |
|
Maltzman Julia D.
Chief Medical Officer
|
— | — | 2026-03-25 |